Glucocorticoids suppress T cell function by up-regulating microRNA-98.

Area of Science:

• Immunology
• Molecular Biology
• Pharmacology

Background:

• Glucocorticoids, like methylprednisolone (MP), are known for their potent anti-inflammatory effects.
• The precise molecular mechanisms underlying steroid-induced T cell suppression are not fully understood.
• MicroRNAs (miRNAs) are emerging as key regulators of cellular processes, including immune responses.

Purpose of the Study:

• To identify specific microRNAs (miRNAs) in human T cells responsible for the anti-inflammatory actions of steroids.
• To elucidate the molecular pathways through which steroids exert their immunosuppressive effects on T cells.

Main Methods:

• Human CD4+ T cells were treated with methylprednisolone (MP) in vitro.
• MicroRNA and messenger RNA expression profiling was performed using microarrays.
• Quantitative polymerase chain reaction (qPCR), flow cytometry, and ELISA were used to validate findings and assess target suppression.
• MiRNA transfection experiments were conducted to confirm mechanistic links.

Main Results:

• Methylprednisolone treatment led to significant changes in miRNA and mRNA expression profiles in T cells.
• The expression of microRNA-98 (miR-98) was notably increased by MP.
• MP suppressed the expression of predicted miR-98 targets, including interleukin-13 and multiple tumor necrosis factor receptors (TNFRs).
• Forced expression of miR-98 mimicked the suppressive effects of MP on these targets.

Conclusions:

• The study identifies a direct link between miR-98 expression and the anti-inflammatory effects of methylprednisolone in T cells.
• Evidence suggests that MP utilizes miR-98 to inhibit specific pro-inflammatory targets, thereby reducing inflammation.
• This finding contributes to understanding the anti-inflammatory mechanisms of glucocorticoids and may aid in developing therapies with fewer side effects.